Recently, a report suggested that the knockdown of AHNAK in a melanoma cell line led to the loss of cadherin-1 and was associated with poor patient outcomes [29], providing evidence that upregulated RNF38 induced a reduction in E-cadherin levels rather than directly interacting with E-cadherin. The gene discussed is CDH1; the disease is melanoma.